EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 151 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $225,511 | -24.7% | 14,300 | -7.1% | 0.01% | -18.2% |
| Q2 2023 | $299,376 | -58.5% | 15,400 | -39.5% | 0.01% | -63.3% |
| Q1 2023 | $722,045 | +240.1% | 25,451 | +250.4% | 0.03% | +172.7% |
| Q4 2022 | $212,327 | -11.2% | 7,264 | +54.6% | 0.01% | -26.7% |
| Q4 2021 | $239,000 | -15.2% | 4,700 | -28.8% | 0.02% | -44.4% |
| Q2 2021 | $282,000 | +22.6% | 6,600 | +20.0% | 0.03% | +28.6% |
| Q1 2021 | $230,000 | – | 5,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |